Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
T-cell surface glycoprotein CD3 zeta chain (CD3ζ or CD247) is a transmembrane protein that is an essential component of the T cell receptor (TCR)-CD3 complex, present on T lymphocytes[1][2][3][6]. The CD3ζ chain, together with other CD3 subunits (gamma, delta, epsilon), associates with TCR alpha/beta (or gamma/delta) heterodimers to form the functional TCR-CD3 complex, which is responsible for antigen recognition and signal transduction during adaptive immune responses[1][3][6][7]. The zeta chain contains three immunoreceptor tyrosine-based activation motifs (ITAMs) in its cytoplasmic domain, which become phosphorylated following TCR engagement, initiating a signaling cascade that leads to T cell activation[3][6][7]. This chain plays a critical role in immune synapse formation, T cell development, and mediating cellular immune responses[5]. Antibodies targeting CD3 (such as muromonab-CD3) are used as immunotherapeutic agents and induce T cell modulation or depletion, though their use carries the risk of significant adverse immune reactions, including cytokine release syndrome[3][6]. CD3ζ is a key biomarker for identifying and studying T cells in research and clinical diagnostics[3][6].
Monoclonal antibodies bind CD3ζ (CD247) or the entire CD3 complex, leading to T cell activation, depletion, or modulation of function - Immunotherapy: anti-CD3 binding leads to TCR signaling, cytokine release, or sometimes T cell apoptosis depending on context and formulation
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T-cell surface glycoprotein CD3 zeta chain (CD3ζ (also known as CD247)).